Lung Heart Rate Variability
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 1/12/2019 |
| Start Date: | January 2, 2019 |
| End Date: | December 2021 |
| Contact: | Mark Leibensperger |
| Email: | mark.leibensperger@uphs.upenn.edu |
| Phone: | 215-615-5644 |
A Pilot Study at a Single Institution of Heart Rate Variability Biofeedback on Lung Cancer Patients Receiving Radiation Thearpy
The purpose of this study is to examine the effects of heart-rate variability biofeedback
training on lung cancer patients receiving definitive radiation therapy. The target
population consists of non-small cell lung cancer (NSCLC) patients receiving 6 weeks of
radiation therapy. The study will utilize the Physiolab GP8 heart rate variability and
respiration system to collect data as well as several survey instruments to analyze quality
of life measures. The goal is to show the HRV training can improve certain QOL measures like
anxiety and sleep quality.
training on lung cancer patients receiving definitive radiation therapy. The target
population consists of non-small cell lung cancer (NSCLC) patients receiving 6 weeks of
radiation therapy. The study will utilize the Physiolab GP8 heart rate variability and
respiration system to collect data as well as several survey instruments to analyze quality
of life measures. The goal is to show the HRV training can improve certain QOL measures like
anxiety and sleep quality.
Inclusion Criteria:
- Participants must be older than 18 years of age
- Both women and men of all ethnic background are eligible to participate in the study.
- Must be diagnosed with non-small cell lung cancer and receiving 6 weeks of radiation
therapy.
- Must be available and willing to participate in 4, approximately 1 hour HRV
biofeedback treatment sessions.
- Signed informed consent
Exclusion Criteria:
- Participant is younger than 18 or older than 70
- Diagnosed with early stage NSCLC
- Patients who are pregnant
- Patients with cardiac arrhythmias
- Patients with Pacemakers
- Patients taking beta-blockers
- Patients with any major mental illness, cognitive impairment
- Incapable of giving informed consent
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
